A carregar...
Engineering HIV-Resistant, Anti-HIV Chimeric Antigen Receptor T Cells
The treatment or cure of HIV infection by cell and gene therapy has been a goal for decades. Recent advances in both gene editing and chimeric antigen receptor (CAR) technology have created new therapeutic possibilities for a variety of diseases. Broadly neutralizing monoclonal antibodies (bNAbs) wi...
Na minha lista:
| Publicado no: | Mol Ther |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Gene & Cell Therapy
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5363191/ https://ncbi.nlm.nih.gov/pubmed/28143740 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2016.12.023 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|